293 related articles for article (PubMed ID: 23362193)
1. Plasma kallikrein-kinin system and diabetic retinopathy.
Liu J; Feener EP
Biol Chem; 2013 Mar; 394(3):319-28. PubMed ID: 23362193
[TBL] [Abstract][Full Text] [Related]
2. The Role of Plasma Kallikrein-Kinin Pathway in the Development of Diabetic Retinopathy: Pathophysiology and Therapeutic Approaches.
Abdulaal M; Haddad NM; Sun JK; Silva PS
Semin Ophthalmol; 2016; 31(1-2):19-24. PubMed ID: 26959125
[TBL] [Abstract][Full Text] [Related]
3. Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy.
Pruneau D; Bélichard P; Sahel JA; Combal JP
Curr Opin Investig Drugs; 2010 May; 11(5):507-14. PubMed ID: 20419596
[TBL] [Abstract][Full Text] [Related]
4. Kinins and Their Receptors as Potential Therapeutic Targets in Retinal Pathologies.
Othman R; Cagnone G; Joyal JS; Vaucher E; Couture R
Cells; 2021 Jul; 10(8):. PubMed ID: 34440682
[TBL] [Abstract][Full Text] [Related]
5. Plasma kallikrein and diabetic macular edema.
Feener EP
Curr Diab Rep; 2010 Aug; 10(4):270-5. PubMed ID: 20535647
[TBL] [Abstract][Full Text] [Related]
6. The kallikrein-kinin system in diabetic retinopathy: lessons for the kidney.
Phipps JA; Feener EP
Kidney Int; 2008 May; 73(10):1114-9. PubMed ID: 18272958
[TBL] [Abstract][Full Text] [Related]
7. G Protein-Coupled Kinin Receptors and Immunity Against Pathogens.
Scharfstein J; Ramos PIP; Barral-Netto M
Adv Immunol; 2017; 136():29-84. PubMed ID: 28950949
[TBL] [Abstract][Full Text] [Related]
8. The kallikrein-kinin system in diabetic retinopathy.
Bhat M; Pouliot M; Couture R; Vaucher E
Prog Drug Res; 2014; 69():111-43. PubMed ID: 25130041
[TBL] [Abstract][Full Text] [Related]
9. The kallikrein-Kinin system modulates the progression of colorectal liver metastases in a mouse model.
da Costa PLN; Wynne D; Fifis T; Nguyen L; Perini M; Christophi C
BMC Cancer; 2018 Apr; 18(1):382. PubMed ID: 29618333
[TBL] [Abstract][Full Text] [Related]
10. Plasma Kallikrein-Kinin system mediates immune-mediated renal injury in trichloroethylene-sensitized mice.
Wang H; Zhang JX; Ye LP; Li SL; Wang F; Zha WS; Shen T; Wu C; Zhu QX
J Immunotoxicol; 2016 Jul; 13(4):567-79. PubMed ID: 27027470
[TBL] [Abstract][Full Text] [Related]
11. Potential Pathways and Pathophysiological Implications of Viral Infection-Driven Activation of Kallikrein-Kinin System (KKS).
Coelho SVA; Augusto FM; Arruda LB
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400022
[TBL] [Abstract][Full Text] [Related]
12. Activation of Factor XII and Kallikrein-Kinin System Combined with Neutrophil Extracellular Trap Formation in Diabetic Retinopathy.
Song DY; Gu JY; Yoo HJ; Kim YI; Nam-Goong IS; Kim ES; Kim HK
Exp Clin Endocrinol Diabetes; 2021 Aug; 129(8):560-565. PubMed ID: 31426112
[TBL] [Abstract][Full Text] [Related]
13. The kallikrein-kinin system in diabetic nephropathy.
Tomita H; Sanford RB; Smithies O; Kakoki M
Kidney Int; 2012 Apr; 81(8):733-44. PubMed ID: 22318421
[TBL] [Abstract][Full Text] [Related]
14. [Kallikrein-kinin system as a target for diabetic retinopathy treatment].
Iarovaia GA; Neshkova EA; Blokhina TB; Kochergin SA; Vorob'eva IV; Gigineishvili DN
Vestn Oftalmol; 2012; 128(4):78-81. PubMed ID: 22994115
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and Lung Mast Cells: The Kallikrein-Kinin Activation Pathway.
Nagashima S; Dutra AA; Arantes MP; Zeni RC; Klein CK; de Oliveira FC; Piper GW; Brenny ID; Pereira MRC; Stocco RB; Martins APC; de Castro EM; Vaz de Paula CB; Amaral ANM; Machado-Souza C; Baena CP; Noronha L
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163636
[TBL] [Abstract][Full Text] [Related]
16. Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema.
Kita T; Clermont AC; Murugesan N; Zhou Q; Fujisawa K; Ishibashi T; Aiello LP; Feener EP
Diabetes; 2015 Oct; 64(10):3588-99. PubMed ID: 25979073
[TBL] [Abstract][Full Text] [Related]
17. The kallikrein-kinin system.
Tang SC; Leung JCK; Lai KN
Contrib Nephrol; 2011; 170():145-155. PubMed ID: 21659767
[TBL] [Abstract][Full Text] [Related]
18. The G Allele of the rs12050217 Polymorphism in the
Brondani LA; Crispim D; Pisco J; Guimarães JA; Berger M
Curr Eye Res; 2019 Sep; 44(9):994-999. PubMed ID: 31017477
[No Abstract] [Full Text] [Related]
19. Angiotensin and bradykinin: targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathy.
Wilkinson-Berka JL; Fletcher EL
Curr Pharm Des; 2004; 10(27):3313-30. PubMed ID: 15544518
[TBL] [Abstract][Full Text] [Related]
20. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation.
Gao BB; Clermont A; Rook S; Fonda SJ; Srinivasan VJ; Wojtkowski M; Fujimoto JG; Avery RL; Arrigg PG; Bursell SE; Aiello LP; Feener EP
Nat Med; 2007 Feb; 13(2):181-8. PubMed ID: 17259996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
